MicroPort® is all about improving human life through the practical application of innovative science. Our aim is to continually develop leading technologies and products for physicians, with life-saving solutions and treatments for patients.
hospitals covered globally
products released to the market
employees from over 30 countries
MicroPort® constantly adheres to a people-centric approach to build a leading and globalized healthcare group, where the patient always comes first, in the area of high-technology therapies represented by minimal invasion.
Thus far, MicroPort® has released about 300 products to the market, covering 10 major business segments, including Cardiovascular Intervention & Structural Heart Diseases, Electrophysiology & Cardiac Rhythm Management, Orthopedics & Soft Tissue Repair, Endovascular & Peripheral Vascular Diseases, Neurovascular Intervention & Neurosciences, Life Sciences (Endocrine Management), Surgical Devices & Medical Robotics, Urology & Gynecology & Respiratory & Gastroenterology, Aesthetics & Rehabilitation, and In vitro Diagnostics & Medical Imaging.
With a head office in Zhang Jiang Science City in Shanghai, China, MicroPort® possesses a large footprint of major production and R&D facilities across the world, including Shanghai, Suzhou, Jiaxing, Dongguan in China, Memphis in the United States, Clamart in France, Saluggia in Italy, and the Dominican Republic, creating a globalized network of R&D, manufacturing, marketing, and services.